ShockWave Medical, Inc. (SWAV) News

ShockWave Medical, Inc. (SWAV): $328.60

0.40 (-0.12%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Filter SWAV News Items

SWAV News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SWAV News Highlights

  • For SWAV, its 30 day story count is now at 6.
  • Over the past 20 days, the trend for SWAV's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about SWAV are DEC.

Latest SWAV News From Around the Web

Below are the latest news stories about SHOCKWAVE MEDICAL INC that investors may wish to consider to help them evaluate SWAV as an investment opportunity.

13 High Growth Healthcare Stocks to Buy

In this article, we will take a look at 13 high growth healthcare stocks to buy. To skip our analysis of the recent market activity, you can go directly to see the 5 Best High Growth Healthcare Stocks to Buy. For the purpose of this article, we have defined high growth stocks as stocks that […]

Yahoo | December 26, 2023

Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

SANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular disease, announced today that the company will be participating in the 42nd Annual J.P. Morgan Healthcare Conference, which is being held from Monday, January 8 to Thursday, January 11, 2024, in San Francisco, CA. Shockwave management is scheduled for a live presentation on Wednesday, Ja

Yahoo | December 20, 2023

Insider Sell Alert: President & CEO Douglas Godshall Sells 5,000 Shares of ShockWave ...

ShockWave Medical Inc (NASDAQ:SWAV) has recently witnessed a significant insider sell by its President &

Yahoo | December 19, 2023

What Makes Shockwave Medical (SWAV) a Potential Investment?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy outperformed the Russell Midcap Growth Index and returned -4.11% (net) while the index return was -5.22%. The third quarter saw a decline in […]

Yahoo | December 18, 2023

Reasons to Invest in Shockwave Medical (SWAV)

ClearBridge Investments, an investment management firm, released its third-quarter 2023 “Mid Cap Growth Strategy” investor letter, a copy of which can be downloaded here. The strategy underperformed its benchmark Russell Midcap Growth Index in the quarter. Overall, the effects of stock selection impacted the performance on a relative basis. The strategy gained three of the 11 […]

Yahoo | December 13, 2023

Shockwave Medical (SWAV) Down 1% Since Last Earnings Report: Can It Rebound?

Shockwave Medical (SWAV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 6, 2023

Shockwave Medical (SWAV) Fell on Concerns Over the New GLP-1 Diabetes/Obesity Drugs

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, its Investor Class fund ARTSX returned -7.98%, Advisor Class fund APDSX posted a return of -7.96%, and Institutional Class fund APHSX returned -7.97%, compared to a […]

Yahoo | December 1, 2023

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Yahoo | November 30, 2023

Insider Sell Alert: President, CCO Isaac Zacharias Offloads 4,000 Shares of ShockWave Medical ...

In a recent transaction on November 27, 2023, Isaac Zacharias, President and Chief Commercial Officer of ShockWave Medical Inc, sold 4,000 shares of the company's stock.

Yahoo | November 29, 2023

Insider Sell Alert: Director Frank Watkins Sells 3,000 Shares of ShockWave Medical Inc (SWAV)

ShockWave Medical Inc (NASDAQ:SWAV), a pioneer in the development and commercialization of intravascular lithotripsy to treat complex calcified cardiovascular disease, has recently witnessed a notable insider transaction.

Yahoo | November 22, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!